Literature DB >> 6699474

Relationship of glutathione levels and Heinz body formation to irreversibly sickled cells in sickle cell anemia.

N Wetterstroem, G J Brewer, J A Warth, A Mitchinson, K Near.   

Abstract

To assess the possibility that the membrane lesion seen in sickle cells involves oxidant damage, we investigated the relationship between irreversibly sickled cells and glutathione levels and Heinz body production. We found that the mean level of red cell glutathione, whether expressed as micromoles per gram of hemoglobin or micromoles per milliliter of cell water, was significantly decreased in 39 patients with sickle cell anemia. A weak but significant negative correlation between glutathione levels and irreversibly sickled cell counts in the patients was observed. Stractan density gradient studies were performed to determine glutathione differences in normal- and abnormal-appearing sickle cells. The percent of abnormal cells in each of the five stractan gradient fractions was negatively correlated with both the micromole per gram of hemoglobin and micromole per milliliter of cell water levels of glutathione. Another indicator of susceptibility to oxidant stress, Heinz body formation, was increased in patients with sickle cell anemia vs controls in response to oxidant stress. Surprisingly, we found that the majority of Heinz bodies were in the non-ISC fraction of cells, rather than in the irreversibly sickled cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6699474

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  9 in total

1.  Old yellow enzyme protects the actin cytoskeleton from oxidative stress.

Authors:  Brian K Haarer; David C Amberg
Journal:  Mol Biol Cell       Date:  2004-08-10       Impact factor: 4.138

2.  Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease.

Authors:  Claudia R Morris; Jung H Suh; Ward Hagar; Sandra Larkin; D Anton Bland; Martin H Steinberg; Elliott P Vichinsky; Mark Shigenaga; Bruce Ames; Frans A Kuypers; Elizabeth S Klings
Journal:  Blood       Date:  2007-09-11       Impact factor: 22.113

3.  Pathological basis of symptoms and crises in sickle cell disorder: implications for counseling and psychotherapy.

Authors:  Oluwatoyin Olatundun Ilesanmi
Journal:  Hematol Rep       Date:  2010-04-13

4.  L-glutamine therapy reduces endothelial adhesion of sickle red blood cells to human umbilical vein endothelial cells.

Authors:  Yutaka Niihara; Neil M Matsui; Yamin M Shen; Dean A Akiyama; Cage S Johnson; M Alenor Sunga; John Magpayo; Stephen H Embury; Vijay K Kalra; Seong Ho Cho; Kouichi R Tanaka
Journal:  BMC Blood Disord       Date:  2005-07-25

5.  Quercetin Completely Ameliorates Hypoxia-Reoxygenation-Induced Pathophysiology Severity in NY1DD Transgenic Sickle Mice: Intrinsic Mild Steady State Pathophysiology of the Disease in NY1DD Is Also Reversed.

Authors:  Sangeetha Thangaswamy; Craig A Branch; Kamalakar Ambadipudi; Seetharama A Acharya
Journal:  Biomolecules       Date:  2021-10-06

Review 6.  Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disorders.

Authors:  Claudia R Morris; Mark T Gladwin; Gregory J Kato
Journal:  Curr Mol Med       Date:  2008-11       Impact factor: 2.222

7.  A posttranslational modification of beta-actin contributes to the slow dissociation of the spectrin-protein 4.1-actin complex of irreversibly sickled cells.

Authors:  A Shartava; C A Monteiro; F A Bencsath; K Schneider; B T Chait; R Gussio; L A Casoria-Scott; A K Shah; C A Heuerman; S R Goodman
Journal:  J Cell Biol       Date:  1995-03       Impact factor: 10.539

8.  Aged garlic extract therapy for sickle cell anemia patients.

Authors:  Junichiro Takasu; Rolando Uykimpang; Maria Sunga; Harunobu Amagase; Yutaka Niihara
Journal:  BMC Blood Disord       Date:  2002-06-19

9.  Plasma Ischemia-Modified Albumin Levels and Dynamic Thiol/Disulfide Balance in Sickle Cell Disease: A Case-Control Study

Authors:  Oğuzhan Özcan; Hüseyin Erdal; Gül İlhan; Damla Demir; Ahmet Burak Gürpınar; Salim Neşelioğlu; Özcan Erel
Journal:  Turk J Haematol       Date:  2018-09-05       Impact factor: 1.831

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.